April 15, 2024

Merck Pcsk9 Elisa

PCSK9 ELISA KIT|Human

EF000203 96 Tests
EUR 826.8

Human IgG antibody Laboratories manufactures the merck pcsk9 elisa reagents distributed by Genprice. The Merck Pcsk9 Elisa reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact pcsk9 elisa. Other Merck products are available in stock. Specificity: Merck Category: Pcsk9 Group: Elisa

True Blue

5mg Ask for price
Description: True Blue

Human true insulin,TI ELISA Kit

96 tests
EUR 528
Description: A quantitative ELISA kit for measuring Human in samples from biological fluids.

Human true insulin(TI)ELISA Kit

48T
EUR 346.8

Human true insulin(TI)ELISA Kit

96T
EUR 559.2

Human True insulin (TI) ELISA Kit

96Т
EUR 799

Human True insulin (TI) ELISA Kit

48 Tests
EUR 325
Description: Human (Homo sapiens)

Human True insulin (TI) ELISA Kit

96 Tests
EUR 610
Description: Human (Homo sapiens)

Elisa information

PCSK9 ELISA Kit (Rat) (OKCD08616)

OKCD08616 96 Wells
EUR 1263.6
Description: Description of target: a soluble zymogen; involved in hepatic growth and differentiation.;Species reactivity: Rat;Application: ELISA;Assay info: ;Sensitivity: < 1.18ng/mL

PCSK9 ELISA Kit (Human) (OKAN04667)

OKAN04667 96 Wells
EUR 950.4
Description: Description of target: This gene encodes a member of the subtilisin-like proprotein convertase family, which includes proteases that process protein and peptide precursors trafficking through regulated or constitutive branches of the secretory pathway. The encoded protein undergoes an autocatalytic processing event with its prosegment in the ER and is constitutively secreted as an inactive protease into the extracellular matrix and trans-Golgi network. It is expressed in liver, intestine and kidney tissues and escorts specific receptors for lysosomal degradation. It plays a role in cholesterol and fatty acid metabolism. Mutations in this gene have been associated with autosomal dominant familial hypercholesterolemia. Alternative splicing results in multiple transcript variants.;Species reactivity: Human;Application: ELISA;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 0.114 ng/mL

PCSK9 ELISA Kit (Mouse) (OKAN05811)

OKAN05811 96 Wells
EUR 950.4
Description: Description of target: ;Species reactivity: Mouse;Application: ELISA;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 6.0 pg/mL

PCSK9 ELISA Kit (Mouse) (OKBB00652)

OKBB00652 96 Wells
EUR 652.8
Description: Description of target: Proprotein convertase subtilisin/kexin type 9, also known as PCSK9, is an enzyme that in humans is encoded by the PCSK9 gene. This gene encodes a proprotein convertase belonging to the proteinase K subfamily of the secretory subtilase family. By genomic sequence analysis, the PCSK9 gene was mapped to chromosome 1p32. This protein plays a major regulatory role in cholesterol homeostasis. PCSK9 binds to the epidermal growth factor-like repeat A (EGF-A) domain of the low-density lipoprotein receptor (LDLR), inducing LDLR degradation. Reduced LDLR levels result in decreased metabolism of low-density lipoproteins (LDL), which could lead to hypercholesterolemia. PCSK9 may also have a role in the differentiation of cortical neurons.;Species reactivity: Mouse;Application: ELISA;Assay info: Assay Methodology: Quantitative Sandwich Immunoassay;Sensitivity: <= 10 pg/mL

PCSK9 ELISA Kit (Human) (OKBB00903)

OKBB00903 96 Wells
EUR 606
Description: Description of target: Proprotein convertase subtilisin/kexin type 9, also known as PCSK9, is an enzyme that in humans is encoded by the PCSK9 gene. This gene encodes a proprotein convertase belonging to the proteinase K subfamily of the secretory subtilase family. By genomic sequence analysis, the PCSK9 gene was mapped to chromosome 1p32. This protein plays a major regulatory role in cholesterol homeostasis. PCSK9 binds to the epidermal growth factor-like repeat A(EGF-A) domain of the low-density lipoprotein receptor(LDLR), inducing LDLR degradation. Reduced LDLR levels result in decreased metabolism of low-density lipoproteins(LDL), which could lead to hypercholesterolemia. PCSK9 may also have a role in the differentiation of cortical neurons.;Species reactivity: Human;Application: ELISA;Assay info: ;Sensitivity: <10pg/ml

PCSK9 ELISA Kit (Mouse) (OKEH04063)

OKEH04063 96 Wells
EUR 652.8
Description: Description of target: Crucial player in the regulation of plasma cholesterol homeostasis. Binds to low-density lipid receptor family members: low density lipoprotein receptor (LDLR), very low density lipoprotein receptor (VLDLR), apolipoprotein E receptor (LRP1/APOER) and apolipoprotein receptor 2 (LRP8/APOER2), and promotes their degradation in intracellular acidic compartments. Acts via a non-proteolytic mechanism to enhance the degradation of the hepatic LDLR through a clathrin LDLRAP1/ARH-mediated pathway. May prevent the recycling of LDLR from endosomes to the cell surface or direct it to lysosomes for degradation. Can induce ubiquitination of LDLR leading to its subsequent degradation. Inhibits intracellular degradation of APOB via the autophagosome/lysosome pathway in a LDLR-independent manner. Involved in the disposal of non-acetylated intermediates of BACE1 in the early secretory pathway. Inhibits epithelial Na+ channel (ENaC)-mediated Na+ absorption by reducing ENaC surface expression primarily by increasing its proteasomal degradation. Regulates neuronal apoptosis via modulation of LRP8/APOER2 levels and related anti-apoptotic signaling pathways.;Species reactivity: Mouse;Application: ;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 7.89 pg/mL

PCSK9 ELISA Kit (Human) (OKCD08614)

OKCD08614 96 Wells
EUR 1170
Description: Description of target: This gene encodes a member of the subtilisin-like proprotein convertase family, which includes proteases that process protein and peptide precursors trafficking through regulated or constitutive branches of the secretory pathway. The encoded protein undergoes an autocatalytic processing event with its prosegment in the ER and is constitutively secreted as an inactive protease into the extracellular matrix and trans-Golgi network. It is expressed in liver, intestine and kidney tissues and escorts specific receptors for lysosomal degradation. It plays a role in cholesterol and fatty acid metabolism. Mutations in this gene have been associated with autosomal dominant familial hypercholesterolemia. Alternative splicing results in multiple transcript variants.;Species reactivity: Human;Application: ELISA;Assay info: ;Sensitivity: < 0.114ng/mL

PCSK9 ELISA Kit (Mouse) (OKCD08615)

OKCD08615 96 Wells
EUR 1201.2
Description: Description of target: Proprotein convertase subtilisin/kexin type 9, also known as PCSK9, is an enzyme that in humans is encoded by the PCSK9 gene. This gene encodes a proprotein convertase belonging to the proteinase K subfamily of the secretory subtilase family. By genomic sequence analysis, the PCSK9 gene was mapped to chromosome 1p32. This protein plays a major regulatory role in cholesterol homeostasis. PCSK9 binds to the epidermal growth factor-like repeat A (EGF-A) domain of the low-density lipoprotein receptor (LDLR), inducing LDLR degradation. Reduced LDLR levels result in decreased metabolism of low-density lipoproteins (LDL), which could lead to hypercholesterolemia. PCSK9 may also have a role in the differentiation of cortical neurons.;Species reactivity: Mouse;Application: ELISA;Assay info: ;Sensitivity: < 6.0pg/mL

PCSK9 ELISA Kit (Monkey) (OKCA01614)

OKCA01614 96 Wells
EUR 1116
Description: Description of target: Crucial player in the regulation of plasma cholesterol homeostasis. Binds to low-density lipid receptor family members: low density lipoprotein receptor (LDLR), very low density lipoprotein receptor (VLDLR), apolipoprotein E receptor (LRP1/APOER) and apolipoprotein receptor 2 (LRP8/APOER2), and promotes their degradation in intracellular acidic compartments. Acts via a non-proteolytic mechanism to enhance the degradation of the hepatic LDLR through a clathrin LDLRAP1/ARH-mediated pathway. May prevent the recycling of LDLR from endosomes to the cell surface or direct it to lysosomes for degradation. Can induce ubiquitination of LDLR leading to its subsequent degradation. Inhibits intracellular degradation of APOB via the autophagosome/lysosome pathway in a LDLR-independent manner. Involved in the disposal of non-acetylated intermediates of BACE1 in the early secretory pathway. Inhibits epithelial Na+ channel (ENaC)-mediated Na+ absorption by reducing ENaC surface expression primarily by increasing its proteasomal degradation. Regulates neuronal apoptosis via modulation of LRP8/APOER2 levels and related anti-apoptotic signaling pathways.;Species reactivity: Monkey;Application: ;Assay info: Assay Methodology: Quantitative Sanadwich ELISA;Sensitivity: 1.1 pg/mL

Nori® Human PCSK9 ELISA Kit

GR111513 96-well
EUR 461

Rat PCSK9 PicoKine ELISA Kit

EK1701 96 wells
EUR 510
Description: For quantitative detection of rat PCSK9 in cell culture supernates, serum and plasma (heparin, EDTA).

Nori® Porcine PCSK9 ELISA Kit

GR113423 96-well
EUR 461

Human PCSK9 PicoKine ELISA Kit

EK1147 96 wells
EUR 510
Description: For quantitative detection of human PCSK9 in cell culture supernates, cell lysates, serum and plasma (heparin, EDTA).

Mouse PCSK9 PicoKine ELISA Kit

EK1148 96 wells
EUR 546
Description: For quantitative detection of mouse PCSK9 in cell culture supernates, cell lysates, serum and plasma (heparin, EDTA).

OKBB01192-96W - Pcsk9 ELISA Kit (Rat)

OKBB01192-96W 96wells
EUR 538

OKEH02981-96W - PCSK9 ELISA Kit (Rat)

OKEH02981-96W 96Wells
EUR 425

OKCD08616-96W - PCSK9 ELISA Kit (Rat)

OKCD08616-96W 96Wells
EUR 850